The operation of healthcare providers differs from that of most other businesses in three important ways:
These factors make it imperative that healthcare providers use the best methods available that will let them improve patient outcomes while controlling the parts of the cost equation that they can control.
This article is one in a series from Strong America Now that illustrate how forward-thinking healthcare providers are using quality improvement methods to meet the dual goals of improving patient outcomes and controlling the costs.
Overview
In recent years, the University of California–San Francisco (UCSF) Medical Center has begun using quality improvement methods in key areas as a way to tackle rising healthcare costs and quality of care challenges. The cardiac surgery group applied basic quality improvement techniques to reduce unnecessary usage of a costly components of care by 19%–27%, for a total annualized savings of $1.2 million.
Problem
When UCSF's Medical Center saw that the cost per case of cardiac surgery had jumped dramatically between 2009 and 2010, they discovered that high use of blood transfusions and Factor VII (a blood-clotting agent) was a major cause. Nearly 100% of cardiac surgery patients received either blood and/or Factor VII transfusions—a rate much higher than the national average (using benchmark data). Initially, there were no common guidelines around use of blood or Factor VII for the Medical Center heart patients.
Approach
UCSF put together a cross-specialty team, including a cardiac surgeon, anesthesiologist, and Lab Medicine-hematology physician to study the problem. Together with other team members, they examined all of the protocols relating to use of blood and Factor VII transfusions for cardiac patients, and used both internal and national data to evaluate the effectiveness of different procedures. The team focused on standardizing care and documenting protocols so that all of the people who provide care to cardiac patients—and the patients themselves—understand what is expected at every stage after surgery. The development of blood and Factor VII protocols reduced variability in utilization, and reduced costs and waste.
Results
Here is a summary of results comparing a 2010 baseline to nine months of FY2011:
CHANGE FROM 2010 BASELINE TO 2011*
| Blood Usage | % of patients receiving blood | % Improvement in blood cost per case | Blood cost per case improvements | |
| Coronary Artery Bypass | Down 20% | Down 2.6% | 26% | $736 |
| Valve surgeries | Down 19% | Down 12.8% | 41% | $1,725 |
| Factor VII usage | % of patients receiving Factor VII | % Improvement in Factor VII cost per case | Factor VII per case improvements | |
| Coronary Artery Bypass | Down 27% | Down 19% | 70% | $4,035 |
| Valve surgeries | Down 21% | Down 13.9% | 24% | $2,913 |
In addition, the Cardiac Surgery team improved the flow of the patient through the hospital and the discharge process, reducing unnecessary hospital days and achieving an overall length of stay reduction of 0.9 days/case. This made 94 beds available for new patients
Lessons Learned
Credits: Thanks to Karen Rago for her help in developing this case study.